TINA-QUANT HBA1C GEN.2— 510(k) K110313

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K110313 for TINA-QUANT HBA1C GEN.2, Substantially Equivalent on 2011-12-23. Applicant: Roche Diagnostics.

Clearance details

Applicant: Roche Diagnostics
Product code: Code LCP
Advisory panel: Hematology
Date received: 2011-02-02
Decision date: 2011-12-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.